FR2727629B1 - - Google Patents

Info

Publication number
FR2727629B1
FR2727629B1 FR9414630A FR9414630A FR2727629B1 FR 2727629 B1 FR2727629 B1 FR 2727629B1 FR 9414630 A FR9414630 A FR 9414630A FR 9414630 A FR9414630 A FR 9414630A FR 2727629 B1 FR2727629 B1 FR 2727629B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9414630A
Other languages
French (fr)
Other versions
FR2727629A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR9414630A priority Critical patent/FR2727629A1/en
Priority to IL11616895A priority patent/IL116168A0/en
Priority to ZA9510184A priority patent/ZA9510184B/en
Priority to TR95/01530A priority patent/TR199501530A1/en
Priority to MA24086A priority patent/MA23737A1/en
Priority to PCT/FR1995/001596 priority patent/WO1996017616A1/en
Priority to SK685-97A priority patent/SK68597A3/en
Priority to JP8517359A priority patent/JPH10509729A/en
Priority to ARP950100438A priority patent/AR002946A1/en
Priority to AU43073/96A priority patent/AU4307396A/en
Priority to CA002207028A priority patent/CA2207028A1/en
Priority to CN95196670A priority patent/CN1168634A/en
Priority to CZ971753A priority patent/CZ175397A3/en
Priority to PL95320564A priority patent/PL320564A1/en
Priority to BR9509961A priority patent/BR9509961A/en
Priority to KR1019970703784A priority patent/KR980700083A/en
Priority to HU9702097A priority patent/HUT77382A/en
Priority to EP95941761A priority patent/EP0797444A1/en
Publication of FR2727629A1 publication Critical patent/FR2727629A1/en
Application granted granted Critical
Publication of FR2727629B1 publication Critical patent/FR2727629B1/fr
Priority to MXPA/A/1997/004105A priority patent/MXPA97004105A/en
Priority to NO972558A priority patent/NO972558L/en
Priority to FI972383A priority patent/FI972383A/en
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR9414630A 1994-12-06 1994-12-06 OSTEOPOROSIS TREATMENT CYCLE KIT Granted FR2727629A1 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (en) 1994-12-06 1994-12-06 OSTEOPOROSIS TREATMENT CYCLE KIT
IL11616895A IL116168A0 (en) 1994-12-06 1995-11-28 Kit for cycle of treatment of osteoporosis
ZA9510184A ZA9510184B (en) 1994-12-06 1995-11-30 Kit for cycle of treatment of osteoporosis
MA24086A MA23737A1 (en) 1994-12-06 1995-12-04 OSTEOPOROSIS TREATMENT CYCLE KIT
TR95/01530A TR199501530A1 (en) 1994-12-06 1995-12-04 Kit for use in the therapeutic cycle in the treatment of osteoporosis.
BR9509961A BR9509961A (en) 1994-12-06 1995-12-05 Osteoporosis treatment cycle kit
JP8517359A JPH10509729A (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
ARP950100438A AR002946A1 (en) 1994-12-06 1995-12-05 A SET FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOPOROSIS IN MAMMALS ACCORDING TO A CYCLIC DIET.
AU43073/96A AU4307396A (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
CA002207028A CA2207028A1 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
PCT/FR1995/001596 WO1996017616A1 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
CZ971753A CZ175397A3 (en) 1994-12-06 1995-12-05 Kit used for treating or prevention of osteoporosis
PL95320564A PL320564A1 (en) 1994-12-06 1995-12-05 Therapeutic set for treating osteoporosis
SK685-97A SK68597A3 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
KR1019970703784A KR980700083A (en) 1994-12-06 1995-12-05 Kit for Osteoporosis Treatment Cycle
HU9702097A HUT77382A (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
EP95941761A EP0797444A1 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
CN95196670A CN1168634A (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
MXPA/A/1997/004105A MXPA97004105A (en) 1994-12-06 1997-06-03 Set for use in a therapeutic treatment cycle of osteoporo
NO972558A NO972558L (en) 1994-12-06 1997-06-05 Set for osteoporosis treatment cycle
FI972383A FI972383A (en) 1994-12-06 1997-06-05 Kit for osteoporosis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (en) 1994-12-06 1994-12-06 OSTEOPOROSIS TREATMENT CYCLE KIT

Publications (2)

Publication Number Publication Date
FR2727629A1 FR2727629A1 (en) 1996-06-07
FR2727629B1 true FR2727629B1 (en) 1997-02-28

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9414630A Granted FR2727629A1 (en) 1994-12-06 1994-12-06 OSTEOPOROSIS TREATMENT CYCLE KIT

Country Status (20)

Country Link
EP (1) EP0797444A1 (en)
JP (1) JPH10509729A (en)
KR (1) KR980700083A (en)
CN (1) CN1168634A (en)
AR (1) AR002946A1 (en)
AU (1) AU4307396A (en)
BR (1) BR9509961A (en)
CA (1) CA2207028A1 (en)
CZ (1) CZ175397A3 (en)
FI (1) FI972383A (en)
FR (1) FR2727629A1 (en)
HU (1) HUT77382A (en)
IL (1) IL116168A0 (en)
MA (1) MA23737A1 (en)
NO (1) NO972558L (en)
PL (1) PL320564A1 (en)
SK (1) SK68597A3 (en)
TR (1) TR199501530A1 (en)
WO (1) WO1996017616A1 (en)
ZA (1) ZA9510184B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
WO2003095029A1 (en) 2002-05-10 2003-11-20 F. Hoffmann-La Roche Ag Bisphosphonic acid for the treatment and prevention of osteoporosis
RU2315603C2 (en) 2002-12-20 2008-01-27 Ф.Хоффманн-Ля Рош Аг Composition with high dose of ibandronat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114473T1 (en) * 1984-04-30 1994-12-15 Procter & Gamble EQUIPMENT FOR USE IN THE TREATMENT OF OSTEOPOROSIS.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DK0648120T3 (en) * 1992-06-30 1998-01-19 Procter & Gamble Pharma Use of phosphonates in the treatment of osteoporosis
FR2694558B1 (en) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate of the disodium salt of 4-chlorophenylthiomethylene bisphosphonic acid, its preparation, the pharmaceutical compositions containing it.

Also Published As

Publication number Publication date
ZA9510184B (en) 1996-06-11
WO1996017616A1 (en) 1996-06-13
BR9509961A (en) 1997-11-25
FI972383A0 (en) 1997-06-05
SK68597A3 (en) 1997-11-05
EP0797444A1 (en) 1997-10-01
AU4307396A (en) 1996-06-26
NO972558L (en) 1997-08-05
PL320564A1 (en) 1997-10-13
JPH10509729A (en) 1998-09-22
FI972383A (en) 1997-06-05
IL116168A0 (en) 1996-01-31
FR2727629A1 (en) 1996-06-07
AR002946A1 (en) 1998-05-27
MA23737A1 (en) 1996-07-01
MX9704105A (en) 1997-09-30
CN1168634A (en) 1997-12-24
TR199501530A1 (en) 1996-10-21
NO972558D0 (en) 1997-06-05
CZ175397A3 (en) 1997-10-15
CA2207028A1 (en) 1996-06-13
HUT77382A (en) 1998-04-28
KR980700083A (en) 1998-03-30

Similar Documents

Publication Publication Date Title
TW269644B (en)
TW285725B (en)
DK0677466T3 (en)
TW279286B (en)
EP0667387A3 (en)
DE69535748D1 (en)
BY1704C1 (en)
ECSMU940035U (en)
ECSDI940191S (en)
ECSDI940193S (en)
ECSDI940187S (en)
ECSDI940184S (en)
ECSDI940213S (en)
ECSDI940183S (en)
ECSDI940182S (en)
ECSDI940180S (en)
DK40195A (en)
ECSMU940033U (en)
CN3027196S (en)
EP0663383A3 (en)
CN3029189S (en)
CN3027523S (en)
CN3027481S (en)
CN3026925S (en)
CN3026487S (en)

Legal Events

Date Code Title Description
ST Notification of lapse